Brief: Catalyst Pharmaceuticals Says FIRDAPSE New Drug Application Submitted in Japan by Partner DyDo Pharma

Catalyst Pharmaceuticals

18/12/2023 11:39

Dec 18 (Reuters) - Catalyst Pharmaceuticals Inc
 CPRX.O :
    * CATALYST PHARMACEUTICALS ANNOUNCES FIRDAPSE® NEW DRUG
APPLICATION SUBMITTED IN JAPAN BY PARTNER DYDO PHARMA

Source text for Eikon:  ID:nGNX5hRv51 
Further company coverage:  CPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))